Nova Eye Medical Limited reported the results of multicentre clinical study which reinforces the surgical utility of the Molteno3 glaucoma drainage device, as compared to the competing Baerveldt device (Johnson & Johnson). The study reported the surgical time of the Molteno3 to be 15.7 minutes faster than the Baerveldt. This constitutes a significant time saving for physicians and permits the optimal utilisation of operation room resources. Clinical outcomes for the Molteno3 were also favourable. Reduction in intraocular pressure (IOP) for the Molteno3 at the 24-month follow-up at 16.6 mmHg, compared to the Baerveldt at 17.0 mmHg. In addition, the overall rates of failure were 27.5% for the Molteno3 compared to 45.5% for the Baerveldt.